Pyrrolo[1,2-a]pyrazin-7-ol, octahydro-3-methyl-, (3R,7S)-rel-
(3S,7R,8AS)-3-methyloctahydropyrrolo-[1,2-a]pyrazin-7-ol
CAS: 1217985-78-8
Molecular Formula: C8H16N2O
Pyrrolo[1,2-a]pyrazin-7-ol, octahydro-3-methyl-, (3R,7S)-rel- - Names and Identifiers
Pyrrolo[1,2-a]pyrazin-7-ol, octahydro-3-methyl-, (3R,7S)-rel- - Physico-chemical Properties
| Molecular Formula | C8H16N2O |
| Molar Mass | 156.23 |
| Storage Condition | Room Temprature |
| Sensitive | Irritant |
| MDL | MFCD12027286 |
Pyrrolo[1,2-a]pyrazin-7-ol, octahydro-3-methyl-, (3R,7S)-rel- - Risk and Safety
| Hazard Class | IRRITANT |
Pyrrolo[1,2-a]pyrazin-7-ol, octahydro-3-methyl-, (3R,7S)-rel- - Introduction
(3S,7R,8AS)-3-methylloctahydrodropyrrolo-[1,2-a]pyrazin-7-ol is an organic compound with the chemical formula C9H16N2O. The following is a description of the properties, uses, preparation and safety information of the compound:
Nature:
-Appearance: Colorless or white crystalline solid.
-Solubility: Soluble in polar solvents such as water and alcohol.
-Melting point: approximately 61-65°C.
-Absorbance: There is a maximum absorption peak in the ultraviolet-visible spectral range.
Use:
(3S,7R,8AS)-3-methylloctahydropyrrolo-[1,2-a]pyrazin-7-ol is an intermediate compound commonly used in the synthesis of biologically active organic compounds. It is often used in drug development as synthetic antibiotics, anti-tumor drugs, immunomodulators, etc.
Preparation Method: The preparation method of
(3S,7R,8AS)-3-methylloctahydropropylrrolo-[1,2-a]pyrazin-7-ol can be obtained by organic synthetic chemical reaction, but the specific synthetic route may be different depending on the desired compound and reaction system. One common method is to carry out the hydrogenation and cyclization reactions using a suitable catalyst or reagent.
Safety Information:
There is no specific report regarding the safety information of the (3S,7R,8AS)-3-methylloctahydropyrrolo-[1,2-a]pyrazin-7-ol. However, like this organic compound, general laboratory safety procedures should be followed when used. Care should be taken to avoid contact with skin, eyes and inhalation of dust or vapors. Wear appropriate protective gloves, glasses and protective face mask during use. If any discomfort or unexplained symptoms occur, discontinue use immediately and seek medical advice. Please read the safety data sheet and relevant operating instructions of the compound carefully before use.
Nature:
-Appearance: Colorless or white crystalline solid.
-Solubility: Soluble in polar solvents such as water and alcohol.
-Melting point: approximately 61-65°C.
-Absorbance: There is a maximum absorption peak in the ultraviolet-visible spectral range.
Use:
(3S,7R,8AS)-3-methylloctahydropyrrolo-[1,2-a]pyrazin-7-ol is an intermediate compound commonly used in the synthesis of biologically active organic compounds. It is often used in drug development as synthetic antibiotics, anti-tumor drugs, immunomodulators, etc.
Preparation Method: The preparation method of
(3S,7R,8AS)-3-methylloctahydropropylrrolo-[1,2-a]pyrazin-7-ol can be obtained by organic synthetic chemical reaction, but the specific synthetic route may be different depending on the desired compound and reaction system. One common method is to carry out the hydrogenation and cyclization reactions using a suitable catalyst or reagent.
Safety Information:
There is no specific report regarding the safety information of the (3S,7R,8AS)-3-methylloctahydropyrrolo-[1,2-a]pyrazin-7-ol. However, like this organic compound, general laboratory safety procedures should be followed when used. Care should be taken to avoid contact with skin, eyes and inhalation of dust or vapors. Wear appropriate protective gloves, glasses and protective face mask during use. If any discomfort or unexplained symptoms occur, discontinue use immediately and seek medical advice. Please read the safety data sheet and relevant operating instructions of the compound carefully before use.
Last Update：2024-04-09 21:54:55
![Pyrrolo[1,2-a]pyrazin-7-ol, octahydro-3-methyl-, (3R,7S)-rel-](http://res.chembk.com/assets/images/structure/1217985-78-8.png)